Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FL135
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,189
Award facts
- Contract value 100% obligated
- $25,189.12 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,189.12 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for pharmaceutical products and medical supplies. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with the DLA Troop Support Medical. The award was finalized on February 4, 2026, with an ultimate completion date of the same day, indicating expedited fulfillment. The place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate operations.
This delivery order draws from AmerisourceBergen's substantial $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical (designated as SPE2DX), which serves as a comprehensive global pharmaceutical support vehicle through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary IDC and utilizes this agreement to supply a broad spectrum of pharmaceutical products, generic and brand-name medications, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The DLA's reliance on AmerisourceBergen reflects the company's established capability to meet critical federal medical procurement requirements through open competition and flexible contract mechanisms.
Quick answers
Who was awarded contract SPE2DU26FL135?
SPE2DU26FL135 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DU26FL135 worth?
The government has obligated $25,189 on SPE2DU26FL135.
Is contract SPE2DU26FL135 an order under another contract?
Yes. SPE2DU26FL135 is a delivery order under SPE2DU25D4118, an indefinite delivery contract.
Was contract SPE2DU26FL135 competed?
The extent of competition for SPE2DU26FL135 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award